James Paul Lang - 14 Mar 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Director
Signature: s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 14 Mar 2025
Transactions value $: $2,443,761
Form type: 4
Filing time: 19 Mar 2025, 19:40:24 UTC
Previous filing: 07 Jan 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPRX	Common Stock	Purchase	$2.44M	+321K	+472.35%	$7.60	389K	14 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.